Stock comparison
IDEXX Laboratories
SANUWAVE Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$42.11B
Sector
Healthcare
SNWV
SANUWAVE Health
Market cap
$137.85M
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | SNWV | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 38D | IDXX |
| Benjamin Graham | 72B | 50C | IDXX |
| Philip Fisher | 67B | 54C | IDXX |
| Peter Lynch | 63C | 100A | SNWV |
| Joel Greenblatt | 75B | 57C | IDXX |
| Charlie Munger | 79B | 51C | IDXX |
| Terry Smith | 76B | 44D | IDXX |
Side-by-side metrics
| Metric | IDXX | SNWV |
|---|---|---|
| Market cap | $42.11B | $137.85M |
| P/E (TTM) | 39.0x | 8.6x |
| EV/EBIT | 31.6x | 27.1x |
| ROIC (TTM) | 40.66% | 11.43% |
| Gross margin | 62.05% | 74.75% |
| Net margin | 24.63% | 36.21% |
| Revenue CAGR 5y | 7.56% | 35.65% |
| EPS CAGR 5y | 10.79% | - |
| Debt / Equity | 0.7x | 3.9x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$42.11Bvs $137.85M+100%
- Debt / Equity0.7xvs 3.9x+82%
- ROIC (TTM)40.66%vs 11.43%+72%
SNWV leads on
- Revenue CAGR 5y35.65%vs 7.56%+79%
- P/E (TTM)8.6xvs 39.0x+78%
- Net margin36.21%vs 24.63%+32%
- Gross margin74.75%vs 62.05%+17%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.